[2] Aronin discovered his passion for pharmaceutical development while shadowing a physician who was treating an epileptic pediatric patient with regular seizures.
Confronted with limited options to stop the seizures other than to remove a portion of the young patient's brain, the doctor pursued an alternative treatment with a dosage of medication that successfully curbed the child's seizures, preventing the life-altering surgery and setting Aronin on his course to become an entrepreneur in the biopharmaceutical industry.
[5][6][7] Prior to Paragon, Aronin founded Ovation Pharmaceuticals LLC in 2000 and served as its chairman and CEO for nine years.
[10] Aronin is also a former chair of MATTER, a start-up center in Chicago for next-generation healthcare technology companies that opened in February 2015.
[17] Aronin is also chair of ChicagoNEXT's bioscience committee, where he spearheaded development of the health technology startup center MATTER.